Note 8 - Accrued Liabilities

9 Months Ended

Mar. 31, 2024

Notes to Financial Statements

Accrued Liabilities [Text Block]

Note 8 - Accrued Liabilities

Accrued liabilities consist of the following:

	March 31,		June 30,
	2024		2023
	(in thousands)
Accrued savings offers	$	16,617	$	15,739
Accrued program liabilities		10,900		11,012
Accrued customer and product related fees		6,148		6,579
Return reserve		4,660		5,777
Accrued employee compensation		3,892		5,675
Other accrued liabilities		1,874		2,017
Total accrued liabilities	$	44,091	$	46,799

Accrued savings offers represent programs for the Company’s patients covered under commercial payor plans in which the cost of a prescription to such patients is discounted. Accrued program liabilities include government and commercial rebates. Accrued customer and product related fees include accrued expenses and deductions for rebates, wholesaler chargebacks and fees, and other product-related fees and deductions such as royalties for Pediatric Portfolio products, accrued distributor fees, and Medicaid liabilities. The return reserve represents the Company’s accrual for estimated product returns. Accrued employee compensation includes sales commissions, paid time off earned, accrued payroll and accrued bonus. Other accrued liabilities consist of various other accruals, none of which individually or in the aggregate represent greater than five percent of total liabilities.